Cargando…
Inflammation and Pharmacological Treatment in Diabetic Retinopathy
Diabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus, is estimated to be the leading cause of new blindness in the working population of developed countries. Primary interventions such as intensive glycemic control, strict blood pressure regulation, and lipid-mo...
Autores principales: | Kaštelan, Snježana, Tomić, Martina, Gverović Antunica, Antonela, Salopek Rabatić, Jasminka, Ljubić, Spomenka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830881/ https://www.ncbi.nlm.nih.gov/pubmed/24288441 http://dx.doi.org/10.1155/2013/213130 |
Ejemplares similares
-
Body Mass Index: A Risk Factor for Retinopathy in Type 2 Diabetic Patients
por: Kaštelan, Snježana, et al.
Publicado: (2013) -
Body Mass Index and Retinopathy in Type 1 Diabetic Patients
por: Kaštelan, Snježana, et al.
Publicado: (2014) -
Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes
por: Tomić, Martina, et al.
Publicado: (2013) -
Traumatic Optic Neuropathy – Case Report with Discussion on Diagnostic Procedures and Therapy
por: Kaštelan, Snježana, et al.
Publicado: (2018) -
Inflammatory and angiogenic biomarkers in diabetic retinopathy
por: Kaštelan, Snježana, et al.
Publicado: (2020)